Ruxolitinib for tocilizumab-refractory severe COVID-19 infection

被引：32
|
作者：
Innes, Andrew J. [1 ,2 ]
Cook, Lucy B. [1 ,2 ]
Marks, Sasha [2 ]
Bataillard, Edward [2 ]
Crossette-Thambiah, Christina [2 ]
Sivasubramaniam, Gayathiri [3 ]
Apperley, Jane [1 ,2 ]
Milojkovic, Dragana [1 ,2 ]
机构：
[1] Imperial Coll London, Ctr Haematol, Dept Immunol & Inflammat, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Haematol, Hammersmith Hosp, London, England
[3] Imperial Coll Healthcare NHS Trust, Dept Resp Med, Hammersmith Hosp, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 04期
关键词：
transplant; infection; COVID-19; immunosupression;
D O I：
10.1111/bjh.16979
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E198 / E200
页数：3
相关论文
共 50 条
  • [1] Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
    de la Calle, Cristina
    Lopez-Medrano, Francisco
    Pablos, Jose Luis
    Lora-Tamayo, Jaime
    Maestro-de La Calle, Guillermo
    Sanchez-Fernandez, Marcos
    Fernandez-Ruiz, Mario
    Perez-Jacoiste Asin, Maria Asuncion
    Caro-Teller, Jose Manuel
    Garcia-Garcia, Rocio
    Catalan, Mercedes
    Martinez-Lopez, Joaquin
    Sevillano, Angel
    Origuen, Julia
    Ripoll, Mar
    San Juan, Rafael
    Lalueza, Antonio
    de Miguel, Borja
    Carretero, Octavio
    Aguilar, Fernando
    Gomez, Carlos
    Paz-Artal, Estela
    Bueno, Hector
    Lumbreras, Carlos
    Aguado, Jose Maria
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 319 - 325
  • [2] The effect of tocilizumab on severe COVID-19 infection: Review of current evidence
    Yakar, Halil Ibrahim
    Pazarli, Ahmet Cemal
    Inonu Koseoglu, Handan
    Kanbay, Asiye
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (01): : 74 - 83
  • [3] Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children
    Edinoff, Amber N.
    Alpaugh, Edward Sanders
    Newgaard, Olivia
    Wajid, Irza
    Klapper, Rachel J.
    Cornett, Elyse M.
    Kaye, Adam M.
    Iyer, Praneet
    Kaye, Alan D.
    LIFE-BASEL, 2023, 13 (04):
  • [4] Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab
    Sandhu, Gagangeet
    Piraino, Samuel T.
    Piticaru, Joshua
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (03) : E275 - E278
  • [5] Real-life prospective study on tocilizumab in severe COVID-19 infection
    Power, L.
    Morarasu, B.
    Sarfaraz, A.
    Basirat, A.
    Rahman, H.
    Donnelly, S.
    Moloney, E.
    Kooblall, M.
    Lane, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Appropriate use of tocilizumab in COVID-19 infection
    Keske, Siran
    Tekin, Suda
    Sait, Bilgin
    Irkoren, Pelin
    Kapmaz, Mahir
    Cimen, Cansu
    Ugur, Semra
    Celebi, Irfan
    Bakir, Veli Oguzalp
    Palaoglu, Erhan
    Senturk, Evren
    Caglayan, Benan
    Cakar, Nahit
    Tabak, Levent
    Ergonul, Onder
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 338 - 343
  • [7] Predictors of mortality in tocilizumab treated severe covid-19
    Pagkratis, K.
    Chrysikos, S.
    Antonakis, E.
    Pandi, A.
    Kosti, C.
    Markatis, E.
    Hillas, G.
    Digalaki, A.
    Koukidou, S.
    Chaini, E.
    Afthinos, A.
    Dimakou, K.
    Papanikolaou, I.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [8] Effective treatment of severe COVID-19 patients with tocilizumab
    Xu, Xiaoling
    Han, Mingfeng
    Li, Tiantian
    Sun, Wei
    Wang, Dongsheng
    Fu, Binqing
    Zhou, Yonggang
    Zheng, Xiaohu
    Yang, Yun
    Li, Xiuyong
    Zhang, Xiaohua
    Pan, Aijun
    Wei, Haiming
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) : 10970 - 10975
  • [9] Severe Thrombocytopenia as a Manifestation of COVID-19 Infection
    Mocan, Mihaela
    Chiorescu, Roxana Mihaela
    Tirnovan, Andrada
    Buksa, Botond Sandor
    Farcas, Anca Daniela
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [10] Tocilizumab and COVID-19
    Chaudhry, Dhruva
    Singh, Pawan K.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (09) : 741 - 743
12345